Tweet BOSTON, MA, Sofregen Medical, (Sofregen), an early stage medical device company, announced today that it has raised $8 million in new funding.

To export Sofregen Medical funding data to PDF and Excel, clickClick here for more funding data on Sofregen MedicalTo export Sofregen Medical funding data to PDF and Excel, click here The company is developing an advanced platform of products based on silk protein - also known as fibroin - that has been shown to have unique properties for tissue support and regeneration.

Mr. Hartmann was previously CEO of MA-based Axsun Technologies and brings decades of successful leadership experience in the medical technology industry.

We will also be advancing the clinical science to support the use of our unique silk protein materials for medical aesthetics."

"Sofregen's technology platform far exceeds anything else in development or on the market today," said Schaison. | To read full story, visit https://startuparound.com/read/1576654207.5537367/Sofregen-Medical-Lands-$8M?ref=audio_experience